Takeda’s Ninlaro Gets Approval from US FDA for Multiple Myeloma
On 20th Nov 2015 the U.S. FDA provided acceptance for (ixazomib) in combo with two other therapies to treat patients
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine